Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 245.40
Bid: 243.20
Ask: 243.80
Change: -3.00 (-1.21%)
Spread: 0.60 (0.247%)
Open: 248.20
High: 249.00
Low: 242.40
Prev. Close: 248.40
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme Effective and Admission

6 Nov 2012 08:54

RNS Number : 4174Q
Man Strategic Holdings PLC
06 November 2012
 



Man Strategic Holdings plc/Man Group plc6 November 2012

New Corporate Structure - Scheme Effective Date and De-Listing of Man Ordinary Shares and Listing of New Holding Company

Man Group plc ("Man") and Man Strategic Holdings plc ("New Man") announce that the First Court Order relating to the Scheme and the related Man Statement of Capital have now been delivered to and registered by the Registrar of Companies and that accordingly the Scheme has become effective today and that New Man is now the holding company of Man and its subsidiaries.

Under the Scheme, Man Shareholders received one New Man Ordinary Share for each Man Ordinary Share held at the Scheme Record Time. Therefore, the total issued ordinary share capital of New Man is 1,820,659,446 ordinary shares of 107 US cents each.

New Man also confirms that the listing of the Man Ordinary Shares on the Official List was cancelled and the Man Ordinary Shares ceased to be admitted to trading on the London Stock Exchange's main market for listed securities with effect from 8.00 a.m. today.

The new ISIN number for New Man's ordinary shares is: GB00B83VD954. New Man will have the same ticker symbol as Man, which will therefore remain as "EMG".

The New Man Ordinary Shares, with a nominal value of 107 US cents each, have been admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities at 8.00 a.m. today.

New Man Ordinary Shares held in uncertificated form were credited to the relevant CREST accounts on or prior to 8.00 a.m. today. Share certificates in respect of New Man Ordinary Shares held in certificated form are expected to be despatched to shareholders by 19 November 2012.

It is expected that the change of name of Man Strategic Holdings plc (company no. 08172396) to Man Group plc and the change of name of Man Group plc (company no. 02921462) to Man Strategic Holdings plc will take effect later today and that New Man will commence trading as Man Group plc with effect from tomorrow. 

Completion of the New Man Reduction of Capital remains subject to confirmation thereof by the Court. It is expected that the Court hearing to confirm the New Man Reduction of Capital will take place tomorrow and that the New Man Reduction of Capital will become effective on 8 November 2012.

The dates stated above are indicative only and will depend on the date upon which the Court confirms the New Man Reduction of Capital. New Man will notify changes to the expected timetable set out above by issuing an announcement through a Regulatory Information Service.

Capitalised terms used but not defined in this announcement have the meanings given to them in the Circular published by Man on 24 September 2012.

 

For further information:

Fiona Smart, Man Group plc +44 20 7144 2030 or email: fiona.smart@man.com

David Waller, Man Group plc +44 20 7144 2121 or email: david.waller@man.com

George Trefgarne, Maitland PR, +44 20 7379 5151

Merrill Lynch International, which is authorised and regulated in the UK by the FSA, has acted exclusively for New Man and no-one else in connection with Admission and will not be responsible to anyone other than New Man for providing the protections afforded to clients of Merrill Lynch International nor for providing advice in relation to Admission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPFKESFAFEF
Date   Source Headline
3rd Sep 20215:47 pmRNSTransaction in Own Shares
3rd Sep 20217:58 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Sep 20217:02 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Sep 20215:56 pmRNSTransaction in Own Shares
2nd Sep 20216:59 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Sep 20216:48 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20215:54 pmRNSTransaction in Own Shares
1st Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
1st Sep 20217:06 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20216:02 pmRNSTransaction in Own Shares
31st Aug 20217:47 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.